Searched for
TELMISARTAN
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...- Deadly fatty liver could be reversed with this surprising two-drug heart combo, as per doctorsDoctors have found hope for fatty liver disease using two common heart drugs. The new study from the University of Barcelona shows this com...
- Pharma market in good health; lifestyle diseases may be risingThe other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the therapy segment, the...
- Linking spurious drugs with legitimate manufacturers has severe reputational, financial impact: IPAThe Indian Pharmaceutical Alliance (IPA) has called for a clear distinction between spurious and sub-standard drugs following a CDSCO repor...
- CDSCO finds 50 common medicines substandard, including those for fever, blood pressure, diabetes, and acid refluxMore than 50 drugs for common conditions like high blood pressure, acid reflux, and erectile dysfunction have been found to be not-of-stand...
- 40 medical devices, bulk drug units take off under PLIMinister for Chemicals and Fertilisers Mansukh Mandaviya said the country has taken a big step towards self-reliance, with the commissionin...
- NPPA fixes retail prices of 23 drug formulationsSimilarly, the retail price of one tablet of Telmisartan, Chlorthalidone & Cilnidipine tablets at Rs 13.17. The retail price of one tablet ...
- NPPA fixes retail price of 74 drug formulationsThe NPPA said it has also revised the ceiling price of 80 scheduled formulations (NLEM 2022) including the one to treat epilepsy and neutro...
- NPPA fixes retail price of 74 drug formulationsThe NPPA said it has also revised the ceiling price of 80 scheduled formulations (NLEM 2022) including the one to treat epilepsy and neutro...
- Glenmark Life IPO opens next week; dates, price band announcedAt the higher end of the price band, the company is expected to raise Rs 1,513.6 crore via its initial shale sale. The promoter holds 100 p...
- Sun Pharma, Alembic recall products in US marketAccording to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019.
- Drug pricing regulator fixes prices of 40 formulation drugsThe regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...
- Key diabetes, anti-cancer drugs among 92 in price-ceiling listThe National Pharmaceutical Pricing Authority said in orders dated August 13 that manufacturers of these drugs will fix their retail prices...
- NPPA fixes retail prices of 14 formulationsDrug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products.
- Alembic Pharma gets USFDA nod for hypertension tabletsUSFDA approves Alembic Pharma's Telmisartan and Amlodipine tablets, generic version of Boehringer Ingelheim Pharmaceuticals Inc's Twynsta t...
- Aurobindo Pharma gets USFDA nod for generic hypertension tabletsAurobindo now has a total of 211 ANDA approvals (183 final approvals including 9 from Aurolife Pharma LLC and 28 tentative approvals) from ...
- Expect 12-15% growth from US market in FY15: Glenn SaldanhaWe did not get any new approval in Q1 and last year also we struggled a little bit in terms of getting product approvals, says Glenn Saldan...
- Glenmark to launch anti-hypertension drug in US, gets USFDA nodGlenmark's current portfolio consists of 92 products authorised for distribution in the US market and 73 ANDAs are pending approval with th...
- Dr Reddy's Laboratories expects 8-10 pc growth in India generics business this fiscalDRL expects its Indian generic market to grow by 8-10% in the current financial year despite challenges such as price erosion due to new dr...
- Cipla in talks to supply drugs to Germany’s BIBoehringer Ingelheim in talks with Cipla for supply of generic drugs to the $17-bn German coa for two drugs.
Load More
